Pharmacogenetics: Making Cancer Treatment Safer and More Effective

ISBN-13: 9789048186174 / Angielski / Twarda / 2010 / 186 str.

William G. Newman

Opis

This is an up-to-date summary of the exciting new field of how genetic testing can tailor more effective prescription in oncology. It provides a core background in genetics and pharmacological principles before covering genetic tests in specific cancer types.

Spis treści

List of Contributing Authors Acknowledgments Introduction William G. Newman Chapter 1: Principles of cancer treatment William G. Newman & Fiona H. Blackhall Chapter 2: Clinical pharmacology and anticancer drugs Cristina Rodríguez-Antona & Julia Kirchheiner Chapter 3: Pharmacogenetics William G. Newman Chapter 4: Pharmacogenetics in the management of breast cancer Sacha J. Howell Chapter 5: Pharmacogenetics in colorectal cancer Roberta Ferraldeschi Chapter 6: Pharmacogenetics in the management of lung cancer Fiona Blackhall Chapter 7: Pharmacogenetics and cancer treatment in children P. Kellie Turner & Gareth J. Veal Chapter 8: Pharmacogenetics in palliative care Andrew A. Somogyi Chapter 9: Genetic predictors of normal tissue response to radiotherapy Catharine M.L. West, Gillian C. Barnett, Alison M. Dunning, Rebecca M. Elliott, Neil G. Burnet Chapter 10: Cancer pharmacogenetics in industry Mireille Cantarini Chapter 11: Ethical issues in pharmacogenetics Tara Clancy Chapter 12: Economics of cancer pharmacogenetics Katherine Payne Chapter 13: Future directions in cancer pharmacogenetics William G. Newman Glossary Subject Index

Blurb

Chemotherapy has made a dramatic difference to improved survival in patients with cancer. However, not all patients respond and some experience serious side effects.

"Pharmacogenetics: Making cancer treatment safer and more effective" is an up to date summary of the exciting new field of how genetic testing can tailor more effective prescription in oncology.

It is targeted at oncologists and professionals involved in the treatment of patients with cancer. It provides a core background in genetics and pharmacological principles before providing chapters from acknowledged experts in the field on genetic tests in specific cancer types, including breast, bowel and lung cancer. Clinical cases are used to illustrate the practical application of this knowledge.

Chapters on ethics, health economics and the industry aspects of pharmacogenetics set out the challenges and opportunities afforded by this new science.